NIH Researchers Discover Potential Therapeutic Target for Degenerative Eye Disease

NIH researchers found AKT2 alterations cause lysosome dysfunction, leading to drusen formation in dry age-related macular degeneration (AMD), suggesting AKT2 as a therapeutic target.